DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Linifanib is an investigational drug.
There have been 11 clinical trials for Linifanib. The most recent clinical trial was a Phase 1 trial, which was initiated on January 1st 2010.
The most common disease conditions in clinical trials are Neoplasms, Neoplasms by Histologic Type, and Colorectal Neoplasms. The leading clinical trial sponsors are Abbott, AbbVie, and BioGene Pharmaceutical Ltd.
Recent Clinical Trials for Linifanib
|Safety, Tolerability and Efficacy of Vaginal Suppositories for Treatment of the Endometriosis||BioGene Pharmaceutical Ltd.||Phase 1/Phase 2|
|A Study Evaluating the Bioavailability of Two Formulations of Linifanib and Food Effect on Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid Tumors||Abbott||Phase 1|
|A Pharmacokinetic Study to Access How the Body Absorbs and Removes Linifanib in Male Patients With Advanced Solid Tumors.||Abbott||Phase 1|